{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:19:36Z","timestamp":1790756376205,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.hlc.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T09:34:08Z","timestamp":1539768848000},"page":"1646-1654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["15-Year Trends in Patients Hospitalised With Heart Failure and Enrolled in an Australian Heart Failure Management Program"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-5090","authenticated-orcid":false,"given":"Nelson","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-162X","authenticated-orcid":false,"given":"Susan","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Tofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2018.10.010_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1472-6963-12-103","article-title":"The health services burden of heart failure: an analysis using linked population health data-sets","volume":"12","author":"Robertson","year":"2012","journal-title":"BMC Health Services Res"},{"issue":"9","key":"10.1016\/j.hlc.2018.10.010_bib0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archinternmed.2012.878","article-title":"The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia","volume":"172","author":"Wong","year":"2012","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.hlc.2018.10.010_bib0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u2018malignant\u2019 than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCOUTCOMES.116.002653","article-title":"Incidence and early outcomes of heart failure in commercially insured and medicare advantage patients, 2006 to 2014","volume":"9","author":"Sangaralingham","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1071-9164(98)90502-4","article-title":"Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The assessment of treatment with lisinopril and survival (ATLAS) trial investigators","volume":"4","author":"Massie","year":"1998","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.hlc.2018.10.010_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCULATIONAHA.117.027551","volume":"138","author":"Chang","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurheartj\/eht278","article-title":"Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden","volume":"35","author":"Barasa","year":"2014","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hlc.2018.10.010_bib0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ejhf.284","article-title":"National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012","volume":"17","author":"Gabet","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.hlc.2018.10.010_bib0060","doi-asserted-by":"crossref","first-page":"E765","DOI":"10.1503\/cmaj.111958","article-title":"Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007","volume":"184","author":"Yeung","year":"2012","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/eurjhf\/hfq027","article-title":"Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of \u2018days alive and out of hospital\u2019 from epidemiological data","volume":"12","author":"Wasywich","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.hlc.2018.10.010_bib0070","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199511023331806","article-title":"A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure","volume":"333","author":"Rich","year":"1995","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.hlc.2018.10.010_bib0075","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hlc.2018.10.010_bib0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCHEARTFAILURE.109.879239","article-title":"Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005","volume":"3","author":"Teng","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.hlc.2018.10.010_bib0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2013.08.001","article-title":"Mild cognitive impairment, screening, and patient perceptions in heart failure patients","volume":"19","author":"Gallagher","year":"2013","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.hlc.2018.10.010_bib0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2017.04.007","article-title":"Cognitive impairment and heart failure: systematic review and meta-analysis","volume":"23","author":"Cannon","year":"2017","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.hlc.2018.10.010_bib0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.115.018006","article-title":"Do self-management interventions work in patients with heart failure? An individual patient data meta-analysis","volume":"133","author":"Jonkman","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2018.10.010_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1440-172X.2012.02010.x","article-title":"Symptom patterns, duration and responses in newly diagnosed patients with heart failure","volume":"18","author":"Gallagher","year":"2012","journal-title":"Int J Nurs Pract"},{"issue":"2","key":"10.1016\/j.hlc.2018.10.010_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ejhf.901","article-title":"Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality","volume":"20","author":"Platz","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.hlc.2018.10.010_bib0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCULATIONAHA.117.033432","article-title":"Temporal trends and clinical consequences of wait-times for trans-catheter aortic valve replacement: a population based study","volume":"138","author":"Elbaz-Greener","year":"2018","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hlc.2018.10.010_bib0120","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000013074.73995.6C","volume":"105","author":"Williams","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ejhf.486","article-title":"Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study","volume":"18","author":"Schmidt","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10741-018-9703-2","article-title":"SGLT2 inhibition and heart failure-current concepts","volume":"23","author":"Custodio","year":"2018","journal-title":"Heart Fail Rev"},{"issue":"25","key":"10.1016\/j.hlc.2018.10.010_bib0135","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.hrthm.2017.12.001","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.athoracsur.2011.07.033","article-title":"Aortic valve replacement in the elderly: the real life","volume":"93","author":"Langanay","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"17","key":"10.1016\/j.hlc.2018.10.010_bib0155","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.10.010_bib0160","article-title":"Predictors of frequent readmissions in patients with heart failure","author":"Wang","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"7","key":"10.1016\/j.hlc.2018.10.010_bib0165","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2018.10.010_bib0170","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hlc.2018.10.010_bib0175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"Authors\/Task Force","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejheart.2005.08.002","article-title":"Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study","volume":"8","author":"Krum","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.hlc.2018.10.010_bib0190","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40266-016-0393-y","article-title":"Treatment with optimal dose angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers has a positive effect on long-term survival in older individuals (aged >70 years) and octogenarians with systolic heart failure","volume":"33","author":"Sargento","year":"2016","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.hlc.2018.10.010_bib0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"2 Suppl 1","key":"10.1016\/j.hlc.2018.10.010_bib0200","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1161\/CIRCOUTCOMES.115.001700","article-title":"\u201cFrailty, thy name is woman\u201d: syndrome of women with heart failure with preserved ejection fraction","volume":"8","author":"Pedrotty","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.hlc.2018.10.010_bib0205","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2009.06.067","article-title":"Treatment of heart failure with normal ejection fraction: an inconvenient truth!","volume":"55","author":"Paulus","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.hlc.2018.10.010_bib0210","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2018.10.010_bib0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cardfail.2018.03.002","article-title":"Incident hyperkalemia, hypokalemia, and clinical outcomes during spironolactone treatment of heart failure with preserved ejection fraction: analysis of the TOPCAT trial","volume":"24","author":"Desai","year":"2018","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hlc.2018.10.010_bib0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.002946","article-title":"Characterization of mineralocorticoid receptor antagonist therapy initiation in high-risk patients with heart failure","volume":"10","author":"Cooper","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T07:02:05Z","timestamp":1571122925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618319516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1443950618319516"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.10.010","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"15-Year Trends in Patients Hospitalised With Heart Failure and Enrolled in an Australian Heart Failure Management Program","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}